Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 3 Ovarian Neoplasms 2 Neoplasms 2 Recurrence 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Intraoral Tumor 1 Esophageal Neoplasms 1 Disease Progression 1 Chalazion 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Brain Edema 1

Interventions

Triamcinolone Acetonide 1 Triamcinolone 1 Sevoflurane 1 Fluorouracil 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Chalazion × Sevoflurane × Clear all

NCT07450495 2026-03-04

SEVO-PED

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Phase NA Recruiting

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡